Urticaria and the risk of cancer: a Danish population-based cohort study
British Journal of Dermatology · 17.10.2024 · 191 (5) · 706-712
DOI: 10.1093/bjd/ljae264 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift British Journal of Dermatology, online erschienen am 27.06.2024. Verfasst von Sissel B T Sørensen und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Aarhus University Hospital, Aarhus, Denmark. Hauptthemen laut MEDLINE: Neoplasms, Urticaria. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 36 Literaturangaben.
Abstract (Originalsprache)
Background
Urticaria has been tentatively linked to cancer, but epidemiological evidence supporting this link is sparse and conflicting. We conducted a population-based cohort study using healthcare databases covering the Danish population (January 1980–December 2022). We followed 87 507 people for a median of 10.1 years after their first hospital contact for urticaria.
Objectives
To examine associations of a hospital diagnosis of urticaria with incident cancer.
Methods
We computed the absolute risk of cancer and standardized incidence ratios (SIRs) with 95% confidence intervals (CIs) standardized to Danish national cancer rates. In a cross-sectional analysis, we examined whether the extent of cancer spread differed between people with vs. without a previous urticaria diagnosis.
Results
The overall SIR for all types of cancer was 1.09 (95% CI 1.06–1.11) based on 7788 observed vs. 7161 expected cases. The risk for any cancer was 0.7% (95% CI 0.6–0.7) for the first year of follow-up. Cancer was diagnosed in 588 people with urticaria during the first year of follow-up (SIR 1.49, 95% CI 1.38–1.62) and in 7200 people thereafter (SIR 1.06, 95% CI 1.04–1.09). During the first year of follow-up, we found strong associations with haematological cancers (e.g. non-Hodgkin lymphoma; SIR 2.91, 95% CI 1.92–4.23). Cancer stage was similar in people with vs. without a previous urticaria diagnosis.
Conclusions
At the time of urticaria diagnosis, or in the first year afterward, we found a large increase in the risk of cancer. In subsequent years, a persistent 6% increase in risk remained. Diagnostic efforts may partly explain the elevated short-term risk, but occult cancer may promote urticaria, or cancer and urticaria share common risk factors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Dermatology, Aarhus University Hospital, Aarhus, Denmark.
- Department of Rheumatology, Aarhus University Hospital, Aarhus, Denmark.
- Department of Clinical Epidemiology, Aarhus University Hospital and Aarhus University, Aarhus, Denmark.
- Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK.
ORCID-Profile: Sissel B T Sørensen, Dóra K Farkas, Christian Vestergaard, Sigrun A J Schmidt, Lise Maria Lindahl, Kathryn E Mansfield, Sinead M Langan, Henrik T Sørensen
Zitieren
APA
Sørensen, S. B. T., Farkas, D. K., Vestergaard, C., Schmidt, S. A. J., Lindahl, L. M., Mansfield, K. E., Langan, S. M., & Sørensen, H. T. (2024). Urticaria and the risk of cancer: a Danish population-based cohort study. British Journal of Dermatology, 191(5), 706-712. https://doi.org/10.1093/bjd/ljae264
Vancouver
Sørensen SBT, Farkas DK, Vestergaard C, Schmidt SAJ, Lindahl LM, Mansfield KE, et al. Urticaria and the risk of cancer: a Danish population-based cohort study. British Journal of Dermatology. 2024;191(5):706-712. doi:10.1093/bjd/ljae264
BibTeX
@article{Srensen2024,
author = {Sørensen, Sissel B T and Farkas, Dóra K and Vestergaard, Christian and Schmidt, Sigrun A J and Lindahl, Lise Maria and Mansfield, Kathryn E and Langan, Sinead M and Sørensen, Henrik T},
title = {Urticaria and the risk of cancer: a Danish population-based cohort study},
journal = {British Journal of Dermatology},
year = {2024},
volume = {191},
number = {5},
pages = {706--712},
doi = {10.1093/bjd/ljae264}
}
EUVIMED